These data support the use of pembrolizumab plus weekly paclitaxel, with or without bevacizumab, as a new standard of care for patients with platinum-resistant, recurrent ovarian cancer,” said ...
A letter from the federal government says that November Food and Nutrition Services (FNS), including SNAP benefits, may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback